title: Re: Twelve-Month Medication Persistence in Men with Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia.
authors.forename: Steven A
authors.initials: SA
authors.lastname: Kaplan
mesh_terms: D058891:5-alpha Reductase Inhibitors / Q000627:therapeutic use*; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D006801:Humans; D059411:Lower Urinary Tract Symptoms / Q000188:drug therapy*; D008297:Male; D011470:Prostatic Hyperplasia / Q000188:drug therapy*; D016903:Drug Monitoring
chemical_list: D058891:5-alpha Reductase Inhibitors; D000319:Adrenergic beta-Antagonists